To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of Mycobacterium Abscessus Infection.

Enrolling by invitation

Conditions studied: Mycobacterium Abscessus Infection, NTM Lung Infection Due to MAC

In brief

The objective of this clinical trial is to evaluate the correlation between clinical efficacy and safety of omadacycline in the treatment of Mycobacterium abscessus infection through retrospective cohort studies. The main questions it aims to answer include: Clinical efficacy of omadacycline in populations stratified by clinical characteristics including age, gender, comorbid immune diseases, albumin level, white blood cell count and pulmonary cavity manifestations on CT.

Key facts

Study ID

NCT07615309

Run by

Beijing Chest Hospital

People needed

200

Starts

2014-01-01

Expected to finish

2029-12-31

Last updated by the study team

2026-05-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Mycobacterium abscessus pulmonary disease confirmed by bacteriological culture or molecular biology testing;
• Age 18 years or older at the time of diagnosis;
• Complete clinical records available for review;
• Treatment duration of at least 1 month.

You may not qualify if…

• Co-infection with other non-tuberculous mycobacterial species;
• Treatment duration less than 1 month;
• Missing key clinical data required for outcome assessment.

Where it is running

• Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis&Thoracic Tumor Research Institute, Beijing, BEIJING 101149 — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.